Sheila Jacobs

Using data from the COVID-19 Global Rheumatology Alliance registry, researchers assessed the association between baseline use of DMARDs and COVID-19 outcomes in patients with rheumatoid arthritis.

Authors presented the case of a 48-year-old woman with rheumatoid arthritis, newly diagnosed microscopic polyangiitis, and a recent COVID-19 infection who stopped taking immunosuppressive therapy.

Researchers evaluated the effects of a web-based strengthening exercise and physical activity program on pain and function in patients with knee osteoarthritis.

Researchers assessed the incidence and potential risk factors for the development of
fenofibrate-associated nephrotoxicity in patients with gout.

Researchers evaluated whether patients with polymyalgia rheumatica with and without elevated acute phase reactants represented distinct subgroups.

In patients with COPD, lockdown for coronavirus disease 2019 (COVID-19) was associated with a reduction in exacerbations and an improvement in symptoms.

The prevalence of chronic neck pain and chronic low back pain has been shown to be higher in patients with COPD compared with individuals without COPD.

Researchers determined the association between severity of periodontitis and osteoarthritis in middle-aged and older adults with type 2 diabetes.

The use of regular, low-dose, oral sustained-release morphine for 4 weeks in patients with COPD and moderate to very severe breathlessness has been shown to improve disease-specific health status.

Patients with asthma and/or chronic obstructive pulmonary disease have an increased risk for the development of long-term lower back pain.